| About NicOx | |||
| Products | |||
|
Naproxcinod NCX 4016 NCX 6560 Full portfolio |
|||
| Maximizing portfolio | |||
| Co-development Research alliances Technology |
|||
| People | |||
|
Board of Directors Management Team Contacts Careers |
|||
| Investor & media | |||
| Press releases Investor relations Fact file Financials Corporate governance Scientific publications Conferences |
|||
| Home | |||
| Directions to NicOx Site en français |
|||
 |
Legal information | ||
|
|||
| Company name: | NicOx SA | ||
| Headquarters: | 1681
route des Dolines Les Taissounieres - Bâtiment HB4 BP 313 06906 SOPHIA ANTIPOLIS Tél : +33 (0)4 97 24 53 00 Fax: +33 (0)4 97 24 53 99 |
||
| Publishing editor: | M. Karl Hanks | ||
| Capital: | EUR 9,435,911.80 | ||
| RCS: | B 403 942 642 | ||
| Web hosting company: | OLEANE / TRANSPAC 33 avenue du Maine 75015 Paris Tél : +33 (0)1 41 21 78 50 |
||
| Site designed by: | Communiquer SARL Garry Crowfoot BP114, 06602 Antibes cedex, France Tel. +33 (0)4 9395 2875 design@communiquer.net |
||